Try it
General Medicine · Cardiology: anticoagulation in valvular AF
Sample itemA patient with moderate-to-severe rheumatic mitral stenosis develops atrial fibrillation. Which anticoagulant is recommended?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Warfarin with target INR 2 to 3
DOACs were inferior to warfarin in patients with rheumatic mitral stenosis (INVICTUS) and in mechanical valves. Vitamin K antagonists remain the standard in valvular AF of this type. Aspirin alone is insufficient for stroke prevention.
Option by option
A. Dabigatran
Dabigatran is not recommended in this setting.
B. Rivaroxaban
Rivaroxaban did worse than VKA in rheumatic AF.
C. Aspirin alone
Aspirin does not adequately prevent cardioembolic stroke.
D. Warfarin with target INR 2 to 3 (correct)
Correct. Warfarin is the drug of choice in AF with significant rheumatic MS.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…